RSV Vaccine Approved by FDA for Adults 60 and Older
The U.S. Food and Drug Administration (FDA) has approved a license for the world’s first respiratory syncytial virus (RSV) vaccine to be given to people 60 years of age and older. Pharmaceutical and biotechnology company GSK (formerly GlaxoSmithKline) has already begun manufacturing doses of the vaccine, which will be sold as early as this fall […]
Doctor Sued for Coercing Minor Children to Get Vaccinated
A mother in Washington, DC is suing a doctor for allegedly forcing her teenaged daughter and son to receive COVID-19 shots without her informed consent. NaToya McNeil claims that Janine Rethy, MD, MPH, chief of community pediatrics at MedStar Georgetown University Hospital, isolated her children in a room in a mobile clinic and refused to […]
Guillain-Barré Syndrome Linked to the RSV Vaccine
The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]
CDC Adds COVID Shots to Recommended Vaccine Schedules for Children and Adults
The U.S. Centers for Disease Control and Prevention (CDC) has updated recommended vaccine schedules for children, adolescents and adults to include the COVID-19 biologics. The move is consistent with recommendations made by the agency’s Advisory Committee on Vaccine Practices (ACIP) in October 2022.1 2 3 4 5 The update of the recommended vaccination schedules was […]
Florida Reports 1,700 Percent Increase in Vaccine Adverse Reactions Reported to VAERS
The Florida Department of Health (DOH) and the State Surgeon General of Florida Joseph A. Ladapo, MD, PhD announced that the Vaccine Adverse Event Reporting System (VAERS) showed a significant increase in reports of COVID-19 vaccine adverse reactions in Florida in the years since the introduction of COVID biologics.1 According to the DOH, since the […]
CDC Advisory Panel Recommends Adding COVID Shots to Child Vaccination Schedule Without FDA License for Use in Children Under 12
On Oct. 20, 2022, the Advisory Committee on Immunization Practices (ACIP) voted 15-0 to add the mRNA COVID-19 shots to the list of vaccines recommended by the U.S. Centers for Disease Control and Prevention (CDC) for children as young as six months old, even though no COVID vaccine has been officially licensed by the U.S. […]
FDA Authorizes COVID Bivalent Shots for Children as Young as Five Years Old
On Oct. 12, 2022, the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) of the COVID bivalent booster versions of messenger RNA (mRNA) Comirnaty and Spikevax biologics developed by Pfizer/BioNTech and Moderna/NIAID for children as young as five or six years old, respectively. The FDA’s decision on Aug. 31 to grant […]
Claims for Injury, Death from COVID Shots Surge
Opinion | The Countermeasures Injury Compensation Program (CICP) is a program of the U.S. government that provide financial compensation for people who have suffered serious injuries or death from vaccines, biologics, antivirals or other drugs, as well medical devices used to “diagnose, prevent or treat a declared pandemic, epidemic or security threat.” The program was […]
U.S. Becomes First Country to Give mRNA COVID Vaccine to Babies
On June 15, 2022 the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) unanimously advised the FDA staff to grant Moderna and Pfizer/BioNTech an Emergency Use Authorization (EUA) amendment to allow their mRNA COVID vaccines to be given to children under age five and as young as […]
Paxlovid Users May Face Rebound SARS-CoV-2
The U.S. Centers for Disease Control and Prevention (CDC) has admitted that COVID-19 patients may experience a rebound SARS-CoV-2 infection after taking Pfizer’s antiviral drug, Paxlovid. Evidence has shown that patients, including those who have gotten COVID shots and been boosted, may suffer a reoccurrence of COVID two to eight days after completing a five-day […]
